Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP : revenue, balance sheet and financial ratios

SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP is a French company founded 11 years ago, specialized in the sector Activités spécialisées, scientifiques et techniques diverses. Based in MISEREY-SALINES (25480), this company of category PME shows in 2021 a net income negative of -114 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP (SIREN 809214646)
Indicator 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C
Net income -113 668 € 99 507 € -206 985 € 42 536 € 74 633 € 21 691 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2021, SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP records a net loss of 114 k€. This deficit will reduce equity on the balance sheet.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-113 668 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 3220%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 3%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

3220.064%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

2.917%

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

43.2%

Solvency indicators evolution
SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP

Sector positioning

Debt ratio
3220.06 2021
2019
2020
2021
Q1: 0.0
Med: 6.26
Q3: 65.01
Watch

In 2021, the debt ratio of SOCIETE D'EXPERTISE EN SC... (3220.06) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
2.92% 2021
2019
2020
2021
Q1: 4.55%
Med: 34.48%
Q3: 64.36%
Average

In 2021, the financial autonomy of SOCIETE D'EXPERTISE EN SC... (2.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 135.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

135.039

Liquidity indicators evolution
SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP

Sector positioning

Liquidity ratio
135.04 2021
2019
2020
2021
Q1: 139.97
Med: 254.23
Q3: 496.51
Watch -50 pts over 3 years

In 2021, the liquidity ratio of SOCIETE D'EXPERTISE EN SC... (135.04) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP in its sector

Comparison with sector Activités spécialisées, scientifiques et techniques diverses

Similar companies (Activités spécialisées, scientifiques et techniques diverses)

Compare SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP with other companies in the same sector:

Voir toutes les statistiques du secteur Activités spécialisées, scientifiques et techniques diverses

Frequently asked questions about SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP

What is the revenue of SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP ?

The revenue of SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP is not publicly disclosed (confidential accounts filed with INPI).

Is SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP profitable?

SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP recorded a net loss in 2021.

Where is the headquarters of SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP ?

The headquarters of SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP is located in MISEREY-SALINES (25480), in the department Doubs.

Where to find the tax return of SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP ?

The tax return of SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP operate?

SOCIETE D'EXPERTISE EN SCIENCES PHARMACOLOGIQUES EN ABREGE SESP operates in the sector Activités spécialisées, scientifiques et techniques diverses (NAF code 74.90B). See the 'Sector positioning' section above to compare the company with its competitors.